Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS HFS Index finishes month with slight gains, up 0.25% in May 2013, 2.18% YTD

Friday, June 21, 2013
Opalesque Industry Update — The UCITS HFS Index continues its positive performance in 2013 with gains of 0.25% in May 2013.

The broad index started positively into the month with profits of 0.36% after the first full week of trading. As the second week of May added additional 0.53% to the performance a positive monthly result was likely, but things turned around in the second half of May: The UCITS HFS Index took a hit of -0.37% in the third week of trading and lost another -0.27% in the last week of the month, reducing the performance significantly. From all funds tracked in the UCITS HFS Index 55.86% reported profits in May 2013.

From a sub-strategy perspective eight out of the twelve sub-strategies reported positive results in May, the best performing being Convertible (1.69%), L/S Equity (1.29%) and Event Driven (0.98%). All three of them made their profits in the first half of the month. While Event Driven was flat for the second half of May, the other two strategies gave up some of their gains in the last two weeks of trading. The worst performing strategies in May were CTA (-1.71%), Fixed Income (-0.70%) and Credit (-0.27%). They all experienced significant losses in the second half of May while not performing well enough in the first two weeks of the month. This means the run of 17 consecutive back-to-back positive monthly results in a row of Fixed Income has come to an end. The only two strategies that are negative in 2013 are Commodity (-2.03%) and Arbitrage (-0.65%). From a year to date perspective the broad UCITS HFS Index now stands at 2.18% in 2013.

The UCITS HFS Index Series is the first index family that tracks all UCITS funds using hedge fund strategies. The UCITS HFS Index Series includes all UCITS III funds that apply absolute return strategies, have more than 10 Mio. € of assets under management, offer at least weekly liquidity and have reported numbers for more than one month. Index tracking funds, long-only and 130/30 strategies are excluded.

The indices are calculated on every Friday and at the end of each month by the index provider 2n20.com AG and are published on the website www.ucitsindex.com .

Press release

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its